Unfavorable Mental Health Outcomes Reported With THC Product Use

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 26, 2025.

via HealthDay

TUESDAY, Aug. 26, 2025 -- High-concentration delta-9-tetrahydrocannabinol (THC) cannabis products are associated with unfavorable mental health outcomes, according to a review published online Aug. 26 in the Annals of Internal Medicine.

Thanitsara Rittiphairoj, M.D., M.P.H., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues systematically reviewed associations of high-concentration THC cannabis products with mental health outcomes. Ninety-nine studies were included (42, 47, and 11 percent randomized trials, observational studies, and other interventional studies, respectively), with 221,097 participants; more than 95 percent had a moderate or high risk for bias.

The researchers found that high-concentration THC products showed consistent unfavorable associations with psychosis or schizophrenia (70 percent) and cannabis use disorder (CUD; 75 percent) in studies not testing for therapeutic effects. For psychosis and schizophrenia, no therapeutic studies reported favorable results. Overall, 53 and 41 percent of nontherapeutic studies reported unfavorable associations for anxiety and depression, respectively, especially among healthy populations. Nearly half of the therapeutic studies revealed benefits for anxiety and depression (47 and 48 percent, respectively), although unfavorable associations were also seen (24 and 30 percent, respectively).

"The findings with regard to anxiety, depression, psychosis or schizophrenia, and CUD are concerning -- even among otherwise healthy persons, potentially including those using the products for recreational purposes -- albeit not definitive for causation and imply a need for precautionary guidance," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-27 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords